Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Philippe Paolantonacci.
Pda Journal of Pharmaceutical Science and Technology | 2018
Philippe Paolantonacci; Philippe Appourchaux; Béatrice Claudel; Monique Ollivier; Richard Dennett; Laurent Siret
Polyvalent human normal immunoglobulins for intravenous use (IVIg), indicated for rare and often severe diseases, are complex plasma-derived protein preparations. A quality by design approach has been used to develop the Laboratoire Français du Fractionnement et des Biotechnologies new-generation IVIg, targeting a high level of purity to generate an enhanced safety profile while maintaining a high level of efficacy. A modular approach of quality by design was implemented consisting of five consecutive steps to cover all the stages from the product design to the final product control strategy. A well-defined target product profile was translated into 27 product quality attributes that formed the basis of the process design. In parallel, a product risk analysis was conducted and identified 19 critical quality attributes among the product quality attributes. Process risk analysis was carried out to establish the links between process parameters and critical quality attributes. Twelve critical steps were identified, and for each of these steps a risk mitigation plan was established. Among the different process risk mitigation exercises, five process robustness studies were conducted at qualified small scale with a design of experiment approach. For each process step, critical process parameters were identified and, for each critical process parameter, proven acceptable ranges were established. The quality risk management and risk mitigation outputs, including verification of proven acceptable ranges, were used to design the process verification exercise at industrial scale. Finally, the control strategy was established using a mix, or hybrid, of the traditional approach plus elements of the quality by design enhanced approach, as illustrated, to more robustly assign material and process controls and in order to securely meet product specifications. The advantages of this quality by design approach were improved process knowledge for industrial design and process validation and a clear justification of the process and product specifications as a basis for control strategy and future comparability exercises.
Archive | 2002
Abdessatar Chtourou; Philippe Paolantonacci; Roland Schmitthaeusler; Jacky Lirochon
Archive | 2006
Abdessatar Chtourou; Frédéric Dhainaut; Philippe Paolantonacci
Archive | 2006
Abdessatar Chtourou; Frédéric Dhainaut; Philippe Paolantonacci
Archive | 2013
Philippe Paolantonacci; Abdessatar Chtourou
Archive | 2013
Philippe Paolantonacci; Abdessatar Chtourou
Archive | 2016
Philippe Paolantonacci; Abdessatar Chtourou
BioDrugs | 2017
Caroline Goussen; Steve Simoneau; Soline Bérend; Christine Jehan-Kimmel; Anne Bellon; Céline Ducloux; Bruno You; Philippe Paolantonacci; Monique Ollivier; Ludovic Burlot; Sami Chtourou; Benoit Flan
Archive | 2012
Monique Ollivier; Philippe Paolantonacci
Archive | 2013
Philippe Paolantonacci; Abdessatar Chtourou